Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
accelerometry
acquired immunodeficiency syndrome
adverse drug reaction
alkylating agents
amphiphysin antibodies
antihistamines
atypical
autoantibodies
autoimmune disease
autonomic dysfunction
autonomic neuropathy
azathioprine
B cell lymphocytes
Barkhof MR criteria for MS
bone marrow suppression
brain atrophy
carcinoma
carcinoma of breast
carcinoma of lung
central nervous system, infection of
cerebellar atrophy, secondary
cerebellar degeneration
cerebral cortex
cerebral cortical atrophy
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, oligoclonal IgG in
cerebrovascular accident, secondary prevention
cladribine
clemastine fumarate
clinicoradiologic dissociation
collapsin response mediator protein 5 IgG
complications
contactin associated protein like 2 antibodies
controversies in neurology
cop 1
cost effectiveness
cyclophosphamide
cyclosporine
dermatomyositis
digital health, wearable technology
disability rating scale, neurological
disability, neurological
disease modifying agents
efficacy
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, paraneoplastic
encephalitis, viral
encephalomyelitis
epidemiology of neurology
evoked potentials
flu-like illness
gadolinium
gait disorder
gammaglobulin therapy, intravenous
ganglionitis
gray matter
herpes virus infection
highly active antiretroviral therapy
human immunodeficiency virus type 1
hypertension
immune reconstitution inflammatory syndrome
immunocompetent
immunologic disease
immunology and the nervous system
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
impotence
infection
interferon
interferon beta 1-a
interferon beta 1-b
JC virus
leucine rich glioma inactivated 1 antibodies
limbic encephalitis
malignancy screen
malignancy, occult
methotrexate
middle cerebellar peduncle
middle cerebellar peduncle, lesion
misdiagnosis
mitoxantrone
monoclonal antibodies
mononeuritis multiplex
motor neuron disease
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, contrast enhanced, delayed
MRI, contrast enhanced, high dose
MRI, demyelinating disease
MRI, diffusion tensor
MRI, diffusion weighted
MRI, false negative
MRI, serial
MRI, volumetry
MRS
multiple sclerosis
multiple sclerosis, benign form of
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, cost of
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, prognosis
multiple sclerosis, prophylaxsis
multiple sclerosis, relapsing
multiple sclerosis, secondary progressive
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
myasthenia gravis, paraneoplastic
myasthenic syndrome
myelopathy
myelopathy, necrotizing
natalizumab
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic disease, multifocal
neurologic examination
neurologic practice
neuromuscular junction
neuronal cell surface antigen
neuronopathy, sensory
neuropathology
neuropathy
neuropathy, paraneoplastic
neuropathy, peripheral
NMDA antagonists
ocrelizumab
onconeural antibodies
opsoclonus-myoclonus syndrome
paraneoplastic cerebellar degeneration
paraparesis
paraparesis, spastic
peripheral nerve, lesion of
placebo
plasmapheresis
pleocytosis of cerebrospinal fluid
practice guidelines
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
psychological testing
quality of life
ReBUILD study
Red flags
rehabilitation for neurologic disorders
remote effect of cancer on the nervous system
remyelination
renal failure
retinopathy
review article
safety
screening
Sjogren's syndrome
Sjogren's syndrome, neurologic manifestations of
steroid
steroid therapy, CNS treatment and complications with
thrombocytopenia
treatment of neurologic disorder
tumor necrosis factor
viral infection
viral infection, CNS
viral infection, reactivation
visual evoked response
visual loss
wheelchair
white matter disease
white matter, dirty-appearing
workup
xerophthalmia
xerostomia
Showing articles 1350 to 1400 of 6278 << Previous Next >>

Randomised Placebo-Controlled Trial of Monthly IVIg Therapy in Relapsing-Remitting MS
Lancet 349:589-593, 5861997., Fazekas,F.,et al, 1997

Offspring Recurrence Rates and Clinical Characteristics of Conjugal Multiple Sclerosis
Lancet 349:1587-1590, Robertson,N.P.,et al, 1997

Amelioration of Refractory Dysesthetic Limb Pain in Multiple Sclerosis by Gabapentin
Neurol 49:304-305, Samkoff,L.M.,et al, 1997

Doctors & Pts Don't Agree:Cross Sectional Study of Pts' & Doctors'Perceptions & Assessments of Disability in MS
BMJ 314:1580-1583, Rothwell,P.M.,et al, 1997

Spinal Pseudoathetosis:A Rare, Forgotten Syndrome, With a Review of Old and Recent Descriptions
Neurol 49:432-437, Ghika,J.&Bogousslavsky,J., 1997

Tizanidine for Spasticity
The Medical Letter 39:62, , 1997

What is the Accuracy of the Clinical Diagnosis of Multiple System Atrophy
Arch Neurol 54:937-944, Litvan,I.,et al, 1997

Generalised Motor Neuron Disease as an Unusual Manifestation of Borrelia Burgdorferi Infection
JNNP 63:257-258, Hemmer,B.,et al, 1997

Epstein-Barr Virus Encephalomyelitis Diagnosed by Polymerase Chain Reaction:Detection of the Genome in the CSF
Neurol 48:1351-1355, Tselis,A.,et al, 1997

Anticytokine Antibodies in Beta Interferon-Trated MS Patients and the Need for Testing
Neurol 49:647-650, Pachner,A.R., 1997

Unusual Causes of Headache
Neurol 48:1494-1499, Ramadan,N.M., 1997

ALS Standard of Care Consensus
Neurol 48 (Suppl 4) :S33-S37997., Miller,R.G.,et al, 1997

Effect of Noninvasive Positive-Pressure Ventilation on Survival in Amyotrophic Lateral Sclerosis
Ann Int Med 127:450-453, Aboussouan,L.S.,et al, 1997

Practice Advisory on the Trtm of ALS with Riluzole
Quality Standards Subcommittee of the AAN, Neurol 49:657-6591997., , 1997

Motor Neuron Syndromes in Cancer Patients
Ann Neurol 41:722-730, 7031997., Forsyth,P.A.,et al, 1997

Familial Nature and Continuing Morbidity of the Amyotrophic Lateral Sclerosis-Parkinsonism Dementia Complex of Guam
Neurol 49:400-409, McGeer,P.L.,et al, 1997

Spinobulbar Muscular Atrophy Can Mimic ALS:The Importance of Genetic Testing in Male Patients with Atypical ALS
Neurol 49:568-572, Parboosingh,J.S.,et al, 1997

Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997

Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997

Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997

Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis
Neurol 48:817-821, Schwid,S.R.,et al, 1997

Glatiramer Acetate for Relapsing Multiple Sclerosis
The Medical Letter 39:61-62, , 1997

Serum Angiotensin-Converting Enzyme in Multiple Sclerosis
Arch Neurol 54:1012-1015, Constantinescu,C.S.,et al, 1997

Hemiageusia:An Unusual Presentation of Multiple Sclerosis
JNNP 54:657, Pascual-Leone,A.,et al, 1997

Serial Neuropsychological Assess & Magnetic Resonance Imagingf Analysis in Multiple Sclerosis
Arch Neurol 54:1018-1025, Hohol,M.J.,et al, 1997

Randomised Trial of Oral and Intravenous Methylprednisolone in Acute Relapses of Multiple Sclerosis
Lancet 349:902-906, 8931997., Barnes,D.,et al, 1997

Frequency and Significance of Antinuclear Antibodies in Multiple Sclerosis
Neurol 49:857-861, Collard,R.C.,et al, 1997

Clinicopath Conf
Oligodendroglioma, Mixed with Low-Grade Astrocytoma, Multiple Sclerosis, Case 12-1997, NEJM 336:1163, 11717., 1997

Concurrence of Multiple Sclerosis and Brain Tumor:Clinical Considerations
Neurol 48:1330-1333, Khan,O.A.,et al, 1997

Olfactory Dysfunction in Multiple Sclerosis
(Letter) NEJM 336:1918-1919997., Doty,R.L.,et al, 1997

Assessment of Olfaction in Multiple Sclerosis:Evidence of Dysfunction by Olfactory Evoked Response and Identification Tests
JNNP 63:145-151, Hawkes,C.H.,et al, 1997

A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997

Paramedian Pontine Infarction
Stroke 28:809-815, Kataoka,S.,et al, 1997

Stroke Recurrence:Predictors, Severity, and Prognosis, The Copenhagen Stroke Study
Neurol 48:891-895, Jorgensen,H.S.,et al, 1997

Adult-Onset Subacute Sclerosing Panecephalitis:Case Reports and Review of the Literature
Mov Dis 12:342-353, Singer,C.,et al, 1997

Hypothermia in Multiple Sclerosis
JNNP 61:369-375, White,K.D.,et al, 1996

Motor Neuron Disease with Parkinsonism
Arch Neurol 53:987-991, Qureshi,A.I.,et al, 1996

Age on Onset, Sex, & Cardiomyopathy as Predictors of Disability and Survival in Friedreich's Disease
Neurol 47:1260-1264, DeMichele,G.,et al, 1996

Clinicopath Conf
Distinguishing Acute Disseminated Encephalomyelitis from Multiple Sclerosis, BMJ 313:802-8041996., , 1996

Treatment of Refractory Urge Urinary Incontinence with Sacral Spinal Nerve Stimulation in Multiple Sclerosis Patients
Lancet 348:717-719, Bosch,J.L.&Broen,J., 1996

Treatment with Oral 3, 4 Diaminopyridine Improves Leg Strength in Multiple Sclerosis Patients
Neurol 47:1457-1462, Bever,C.T.,et al, 1996

Linomide Reduces the Rate of Active Lesions in Relapsing-Remitting Multiple Sclerosis
Neurol 47:895-900, Anderson,O.,et al, 1996

Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996

Increased Writing Activity in Neurological Conditions:A Review and Clinical Study
JNNP 61:510-514, vanVugt,P.,et al, 1996

Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996

Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996

Cranial Nerve Enhancement on Three-Dimentional MRI in Miller Fisher Syndrome
Neurol 47:1601-1602, Nagaoka,U.,et al, 1996

Refractory Epilepsy:Comparison of MR Imaging, CT, and Histopathologic Findings in 117 Patients
Radiology 201:97-105, Bronen,R.A.,et al, 1996

Bilateral Ptosis Due to Mesencephalic Lesions with Relative Preservation of Ocular Motility
J Neuro-Ophthalmol 16:258-263, Martin,T.J.,et al, 1996

Three Get Ready
Arch Neurol 53:1222-1223, Goldblatt,D., 1996



Showing articles 1350 to 1400 of 6278 << Previous Next >>